Treatment

Placebo is a sterile solution in a single use prefilled syringe (PFS) intended for subcutaneous administration clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of subcutaneous sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (M1095-HS-302)
This study is testing a new medicine, sonelokimab, for adults with moderate to severe hidradenitis suppurativa (HS). It compares the new medicine to a dummy treatment (placebo) to see if it's safe and helps improve HS over 16 weeks.
For: hidradenitis suppurativa (HS)
Netherlands · Slovakia · Czechia
Ongoing, recruitingTherapeutic confirmatory (Phase III)
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of subcutaneous sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (M1095-HS-301)
This study is testing a new medicine, sonelokimab, for adults with moderate to severe hidradenitis suppurativa (HS). It compares sonelokimab to a dummy treatment (placebo) to see if it improves HS symptoms and is safe to use.
For: hidradenitis suppurativa (HS)
Norway · Italy · Poland